Compare CACI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CACI | BAX |
|---|---|---|
| Founded | 1962 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.1B |
| IPO Year | 2007 | 1994 |
| Metric | CACI | BAX |
|---|---|---|
| Price | $669.48 | $27.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | ★ $689.50 | $21.00 |
| AVG Volume (30 Days) | 282.9K | ★ 7.5M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 8.24 | N/A |
| EPS | ★ 24.16 | 0.21 |
| Revenue | $4,467,860,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $12.42 | $1.96 |
| Revenue Next Year | $10.00 | $2.22 |
| P/E Ratio | ★ $26.78 | $132.88 |
| Revenue Growth | 2.60 | ★ 5.72 |
| 52 Week Low | $434.70 | $15.73 |
| 52 Week High | $683.50 | $30.00 |
| Indicator | CACI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 79.50 | 68.89 |
| Support Level | $542.29 | $18.58 |
| Resistance Level | $683.50 | $30.00 |
| Average True Range (ATR) | 24.74 | 1.18 |
| MACD | 20.10 | 0.21 |
| Stochastic Oscillator | 96.45 | 73.26 |
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.